Bendamustine Injection, Powder, Lyophilized, For Solution
Product Images NDC 71288-103

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bendamustine (NDC 71288-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Ben0e 0004 01)

Chemical structure of Bendamustine HCl, showing its molecular configuration with chlorine, nitrogen, carbon, hydrogen, and oxygen atoms arranged in the depicted pattern.*

FDA Label Image

Figure 1 (Ben0e 0004 02)

A line graph titled 'Progression-Free Survival' showing survival distribution function over time in months. It compares study treatments including Bendamustine HCl and Chlorambucil, with survival rates decreasing over time on the x-axis for each treatment group.*

FDA Label Image

Principal Display Panel – Bendamustine HCl For Injection, Usp 25 mg Vial Label (Ben0e 0004 03)

Label for Bendamustine HCl Injection, USP, 25 mg per vial, lyophilized powder for solution. It is a single-dose vial for intravenous infusion only, requiring reconstitution and dilution. The label includes usage instructions, storage conditions, and manufacturer details for Meitheal Pharmaceuticals Inc.*

FDA Label Image

Principal Display Panel – Bendamustine HCl For Injection, Usp 25 mg Carton (Ben0e 0004 04 V2)

The packaging label for Bendamustine HCl for Injection, USP, 25 mg per vial, lyophilized powder for intravenous infusion, from Meitheal Pharmaceuticals Inc. The label indicates it is a single-dose vial, with instructions for reconstitution and dilution, storage conditions, and a cytotoxic agent warning. It includes barcodes and manufacturer details, with a QR code panel marked for presentation purposes only.*

FDA Label Image

Principal Display Panel – Bendamustine HCl For Injection, Usp 100 mg Vial Label (Ben0e 0004 05 V2)

Label for Bendamustine HCl for Injection, USP, 100 mg per vial, lyophilized powder for injection by intravenous infusion. The vial is single-dose and cytotoxic. Label includes dosing instructions, reconstitution details, storage conditions, and identifies Meitheal Pharmaceuticals Inc. as the manufacturer, with product made in China.*

FDA Label Image

Principal Display Panel – Bendamustine HCl For Injection, Usp 100 mg Carton (Ben0e 0004 06 V2)

Packaging label for Bendamustine HCl Injection, USP, 100 mg per vial, lyophilized powder for solution, intended for intravenous infusion. The label features dosage and storage instructions, a cytotoxic agent warning, and branding by Meitheal Pharmaceuticals Inc. The label includes a barcode and instructions to retain in carton until use and discard unused portions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.